Advanced Bioengineering

DNA. Antibodies. Cell lines

A Fully Integrated Ecosystem

Every path to discovery is different. We focus on your goals and work hand in hand with you to achieve them. Whether you need codon optimization, recombinant protein production, antibody humanization and engineering, or cell line development, ATUM delivers solutions to advance your research and speed your path to market.

We think of projects more as a collaboration than services. We combine your expertise with our expertise so that together we succeed. Whether you are selecting the best vector and codon optimization for a gene to express in your own lab, or you want us to take you from hybridoma sequence to high producing cell line, our team is ready to help.

ATUM In The World

No data was found
July 9, 2024
The Biopharma Industry is Well Prepared for an Overhaul of the Lead-to-Clinic CMC Process for Antibodies
February 22, 2024
Mitigating the aggregation challenge in immunocytokine production: Strategies during cell line development and purification optimization
February 6, 2024
Directed Evolution for Protein Engineering
January 10, 2024
Pharma Turns to New Tech for Biologics
January 4, 2024
Nanobodies to multiple spike variants and inhalation of nanobody-containing aerosols neutralize SARS-CoV-2 in cell culture and hamsters
December 1, 2021
Will we be protected from COVID-19’s omicron variant? Bay Area researchers sprint to find out
March 19, 2021
Fighting for Our Lives
March 19, 2021
Inom en timme hade vi tio rush-orders
July 26, 2020
Biotech firm rebounds to combat coronavirus

Share

Search

Skip to content